HMGCR and Hypercholesterolemia: Pravastatin, an inhibitor of HMG-CoA reductase, is widely used to treat hypercholesterolemia and has been reported to have therapeutic effects in a range of inflammatory conditions (Rosenson, 1999; Nakamura et al., 2006).